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Background: Adventitial cystic disease (ACD) is an unusual arteriopathy; case reports and small series constitute the
available literature regarding treatment. We sought to examine the presentation, contemporary management, and long-
term outcomes using a multi-institutional database.
Methods: Using a standardized database, 14 institutions retrospectively collected demographics, comorbidities, pre-
sentation/symptoms, imaging, treatment, and follow-up data on consecutive patients treated for ACD during a 10-year
period, using Society for Vascular Surgery reporting standards for limb ischemia. Univariate and multivariate analyses
were performed comparing treatment methods and factors associated with recurrent intervention. Life-table analysis
was performed to estimate the freedom from reintervention in comparing the various treatment modalities.
Results: Forty-seven patients (32 men, 15 women; mean age, 43 years) were identiﬁed with ACD involving the popliteal
artery (n ¼ 41), radial artery (n ¼ 3), superﬁcial/common femoral artery (n ¼ 2), and common femoral vein (n ¼ 1). Lower
extremity claudication was seen in 93% of ACD of the leg arteries, whereas patients with upper extremity ACD had hand
or arm pain. Preoperative diagnosis was made in 88% of patients, primarily using cross-sectional imaging of the lower
extremity; mean lower extremity ankle-brachial index was 0.71 in the affected limb. Forty-one patients with lower
extremity ACD underwent operative repair (resection with interposition graft, 21 patients; cyst resection, 13 patients; cyst
resection with bypass graft, 5 patients; cyst resection with patch, 2 patients). Two patients with upper extremity ACD
underwent cyst drainage without resection or arterial reconstruction. Complications, including graft infection, throm-
bosis, hematoma, and wound dehiscence, occurred in 12% of patients. Mean lower extremity ankle-brachial index at
3 months postoperatively improved to 1.07 (P < .001), with an overall mean follow-up of 20 months (range, 0.33-9 years).
Eight patients (18%) with lower extremity arterial ACD required reintervention (redo cyst resection, one; thrombectomy,
three; redo bypass, one; balloon angioplasty, three) after a mean of 70 days with symptom relief in 88%. Lower extremity
patients who underwent cyst resection and interposition or bypass graft were less likely to require reintervention (P ¼ .04).
One patient with lower extremity ACD required an above-knee amputation for extensive tissue loss.
Conclusions: This multi-institutional, contemporary experience of ACD examines the treatment and outcomes of ACD.
The majority of patients can be identiﬁed preoperatively; surgical repair, consisting of cyst excision with arterial recon-
struction or bypass alone, provides the best long-term symptomatic relief and reduced need for intervention to maintain
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January 2017Adventitial cystic disease (ACD) is a rare, nonatheroscler-
otic arteriopathy, predominantly affecting the arteries of
the lower extremity. Since its original description in
1947,1 our understanding of the disease is based predom-
inantly on individual case reports and collective reviews of
case reports. The prevalence of this arteriopathy remains
unknown, with an estimated 500 cases reported in the
literature.2 This disease primarily affects the popliteal ar-
teries, with accumulation of mucinous or gelatinous ma-
terial in the adventitia of the vessel wall. The initial
diagnosis is usually made during assessment of claudica-
tion in young patients, but currently there is no uniform
approach to the diagnosis or management of these pa-
tients. Treatment options include cyst drainage or exci-
sion alone, interposition graft or bypass without cyst
resection, and interposition graft or bypass with cyst
resection.
The aim of this multicenter study was to identify cur-
rent practice patterns in the diagnosis of ACD patients
and to determine differences in outcomes after the
various treatment options.METHODS
Patients included in this study were identiﬁed at multi-
ple institutions that collaborated on this project and
were treated for ACD between 2005 and 2015. Patients
were identiﬁed by pre-existing institutional vascular dis-
ease databases, in addition to searching of pathology
and radiology hospital records as well as billing data-
bases and operating log books. International Classiﬁca-
tion of Diseases, Ninth Revision codes 443.9 (peripheral
arterial disease not otherwise speciﬁed) and 447.8 (other
speciﬁed disorders of arteries and arterioles) were also
used for disease identiﬁcation as there is no speciﬁc
code for ACD. Diagnosis of ACD was conﬁrmed patholog-
ically. Primary study end points were amputation and
need for reintervention.
Vascular Low-Frequency Disease Consortium (VLFDC)
and database management. The methodology of the
VLFDC process has been described previously in detail.3,4
It was the responsibility of the principal investigator at
each institution to obtain Institutional Review Board
(IRB) approval; all IRBs waived patient consent because
of the minimal risk and retrospective nature of the study.
After IRB approval, patients were identiﬁed, standardized
data were collected using Society for Vascular Surgery
reporting standards for lower extremity ischemia,5 and
then the data were deidentiﬁed and transmitted to the
VLFDC at the University of California Los Angeles, where
data were stored in a secure server. The principal in-
vestigators from each institution were responsible for the
validity and completeness of submitted data from their
institutions. All VLFDC investigators reviewed the collec-
tive data before abstract submission, meeting presenta-
tion, and manuscript submission.Statistics. Data were collected and maintained in an
Excel v16.0 database (Microsoft Corp, Redmond, Wash).
Statistical analysis was performed with SPSS Statistics
v24.0 software (IBM Corp, Armonk, NY) and Prism 7.0
software (Graph Pad Software, La Jolla, Calif). Continuous
variables are presented as mean 6 standard deviation
(SD) unless otherwise noted. Differences between sub-
groups were analyzed using paired Student t-test, anal-
ysis of variance, Kruskal-Wallis test, and Mann-Whitney
U test. Unless numeric values are given, percentages
are not inclusive. Differences between subgroups of
noncontiguous variables were analyzed using c2 test and
Fisher exact test. Multivariable analysis was performed
using binary and multinomial logistic regression models.
Time-dependent variables were analyzed using Kaplan-
Meier life tables. A P value < .05 was considered signiﬁ-
cant. Only the patient’s primary treatment was included
in the analysis; any subsequent procedures are stated for
completeness but not considered for analysis. Unless
stated otherwise, analysis of treatment and outcomes
includes only patients with lower extremity arterial ACD.
RESULTS
Patient demographics and comorbidities. A total of 47
patients (32 male, 15 female) were treated for ACD at 14
institutions (range, 1-10 cases per institution). The major-
ity of ACD cases (43/47 [92%]) were lower extremity arte-
rial lesions, with 41 (95%) located in the popliteal artery
and 2 (5%) within the femoral artery. The remaining pa-
tients had lesions in the radial arteries (n ¼ 3 [6%]) and
common femoral vein (n ¼ 1 [2%]; Table I). Patients
with lower extremity arterial ACD had a mean age of
43 years (range, 25-68 years), and the majority were male
(n ¼ 32 [74%]). Hypertension was the most common
comorbidity, occurring in 12 (28%), and the majority of
patients (30/43 [70%]) were current smokers or ex-
smokers (Table II).
Symptoms/presentation and diagnosis. Most patients
with lower extremity arterial ACD presented with claudi-
cation (93%), although two had ischemic rest pain and
one had tissue loss. The mean ankle-brachial index at
initial evaluation was 0.7 (range, 0.25-1.2; SD, 0.26) and
most patients (38/43 [88%]) were diagnosed with ACD
preoperatively. Of these patients, 29 of 38 (76%) had
cross-sectional imaging with either computed tomog-
raphy angiography or magnetic resonance imaging/
magnetic resonance angiography; only 9 patients un-
derwent preoperative diagnostic catheter angiography
(Table III).
Treatment. Surgical treatmentwasperformed in 41 of 43
(95%) lower extremity patients; the remaining two pa-
tients underwent percutaneous cyst drainage. All proced-
ures were performed by vascular surgeons. The most
commonprocedure usedwas cyst resectionwith interpo-
sition graft (49%), followed by cyst resection and cyst
Table I. Patients with nonlower extremity arterial adventitial cystic disease (ACD)
Patient
Location of
lesion
Patient
demographics Diagnosis Treatment Outcome
1 Radial artery 54-year-old
woman
MRI Cyst excision 6-month follow-up with no recurrence,
symptoms, or loss of patency
2 Radial artery 46-year-old
woman
MRI Cyst excision 4-month follow-up with no recurrence,
symptoms, or loss of patency
3 Radial artery 62-year-old
woman
MRI No treatment 9-month follow-up, still symptomatic
4 Common
femoral vein
55-year-old
woman
CTA/MRI Cyst excision 30-day follow-up with no recurrence of
symptoms and a patent vein
CTA, Computed tomography angiography; MRI, magnetic resonance imaging.
Table II. Comorbidities of patients with lower extremity
arterial adventitial cystic disease (ACD; N ¼ 43 patients)
Comorbidity No. (%)
Current smoker or ex-smoker 30 (70)
Hypertension 12 (28)
Dyslipidemia 4 (10)
Hyperlipidemia 3 (7)
Diabetes mellitus 3 (7)
Table III. Imaging modalities used for preoperative diag-
nosis of lower extremity arterial adventitial cystic disease
(ACD; N ¼ 38 patients)
Imaging modality No. (%)
Duplex ultrasound 30 (79)
MRI/MRA 18 (47)
CTA 16 (42)
Catheter angiography 14 (37)
CTA, Computed tomography angiography; MRA, magnetic resonance
angiography; MRI, magnetic resonance imaging.
Table IV. Procedures performed on patients with lower
extremity arterial adventitial cystic disease (ACD)
Procedure No. (%)
Cyst drainage without resection 2 (5)
Cyst resection 13 (30)
Cyst resection with patch 2 (5)
Cyst resection with interposition graft 21 (49)
Cyst resection with bypass graft 5 (12)
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approach to the popliteal artery. Overall, 26 of 43 (61%)
patients underwent bypass (with or without cyst resec-
tion), and vein was the conduit of choice in 92% of the
patients. There was no correlation between patient char-
acteristics or comorbidities and patient management.
One patient with end-stage renal disease and numerous
other comorbidities underwent primary amputation forextensive tissue loss after being lost to follow-up for
several years. Themean length of hospital stay was 7 days
(range, 1-27 days; SD, 6 days), with amean time to return to
work of 21 days (range, 2-90 days; SD, 17 days). Symptom-
atic relief was universal, and postoperative ankle-brachial
index improved to 1.07 (SD, 0.22; compared with preop-
erative, 0.7; P < .01). There were no differences in compli-
cations, length of hospital stay, or time to return to work
on the basis of treatment, and no perioperative deaths
occurred within 30 days of procedure (Table V). Required
follow-up procedures to maintain patency included
thrombectomy (three), balloon angioplasty (three), redo
cyst resection (one), and redobypass (one). Themean time
from initial index procedure to secondary intervention to
maintain patency was 70 days.
Mean follow-up for all patients was 20 months. Repair
with bypass procedure (with or without cyst resection)
resulted in longer freedom from reoperation than did
cyst excision or drainage alone or with patch of the
affected artery (Fig). Only one patient who underwent
bypass had loss of patency, which was identiﬁed at
6 years and treated with balloon angioplasty. One patient
who underwent percutaneous needle aspiration (cyst
drainage without reconstruction) required surgical revi-
sion with cyst resection and interposition graft 3 weeks
after the initial drainage was performed because of
recurrence of symptoms and the cystic mass. The cystic
lesion recurred in one patient who initially had cyst
resection only; treatment was repeated cyst resection.
DISCUSSION
ACD is a rare disease whose treatment has previously
been based on experience documented in case reports.
Through use of a multi-institutional data collection pro-
cess, we were able to identify a large cohort of patients
with ACD and to determine current diagnostic and treat-
ment approaches; our series is the largest reported in the
literature. Similar to previously published case reports,2
the popliteal artery was the most common site for
involvement. Other arteries reported to be involved
include the radial, external iliac,6 femoral,7 and axillary ar-
teries8; there has also been an occasional case reported in
Fig. A, Freedom from reoperation after primary interven-
tion for patients with lower extremity arterial adventitial
cystic disease (ACD) grouped by operation type (cyst exci-
sion with interposition graft and cyst excision with bypass
graft vs cyst drainage alone, cyst excision only, and cyst
excision with patch). Standard error exceeds 10% at time
points >5 months. B, Freedom from reoperation after pri-
mary intervention for patients with lower extremity arterial
ACD grouped by operation type (cyst excision with inter-
position graft and cyst excision with bypass graft vs cyst
excision only and cyst excision with patch vs cyst drainage
only). Standarderrorexceeds 10%at timepoints>4months.
Table V. Postoperative data for patients with lower extremity arterial adventitial cystic disease (ACD)
Cyst drainage
without resection
Cyst
resection
Cyst resection
with patch
Cyst resection with
interposition graft
Cyst drainage
with bypass P value
Length of hospital stay 2 5 7 9 4 .13
Complications 0 2 1 1 1 .40
Time to return to work 14 23 16 18 30 .11
Follow-up procedures 1 (50%) 3 (23%) 1 (50%) 1 (50%) 2 (40%) .37
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January 2017the venous system. Case reports as well as our own indi-
cate that ACD is an arteriopathy that affects primarily
young men, who had a mean age of 43 years.2,9 As
opposed to prior reports, our series revealed a high per-
centage of patients with a history of smoking; 71% of our
patients were either active smokers or ex-smokers, sug-
gesting that the disease entity should be considered
in the differential diagnosis of any young patient with
claudication, irrespective of smoking status. These cysts
have been suggested to form secondary to adventitial
degeneration as a result of trauma, to be remnantmesenchymal rests during development, or to arise
from synovial origins,10 which may imply that smoking is
a noncausal association, although the exact pathogenesis
of ACD is poorly understood and controversial.
Similar to previous reports,2,9 most patients in our series
presented with claudication (93%), although one patient
withextensive tissue loss requiredanamputationbecause
of a nonsalvageable limb, whereas patients with venous
involvement generally had symptoms such .as swelling,
resulting from local compression. In contrast to earlier re-
ports that identiﬁed the angiographic “scimitar” sign as
pathognomonic for ACD, the majority of the patients in
our series (76%) did not have catheter angiography but
rather had their diagnosis made preoperatively by nonin-
vasive duplex ultrasound, whereas cross-sectional imag-
ing with contrast-enhanced computed tomography or
magnetic resonance imaging11 was used for detailed
anatomic information before treatment. Cross-sectional
imaging studies alsoprovided informationabout thepres-
ence or absence of communication with the joint cavity.
Communicationwith the joint cavity supports themesen-
chymal migration theory of ACD etiology that proposes
that during development, mesenchymal cells migrate
from the joint tendon to the adjacent arterial (or venous)
adventitia, resulting in the formation of the cyst by the
mucin-secreting cells.
Various treatment options exist for ACD, ranging from
ultrasound-guided aspiration to open cyst excision, patch
angioplasty, interpositiongraft, andbypasswithorwithout
cyst excision.2,7,9 In our series, bypass with or without cyst
excision provided the most durable option for symptom-
atic relief as well as resulting in longer freedom from rein-
tervention. One patient had recurrence after initial
treatment with local cyst excision. This patient required
repeated cyst excision and currently remains free of
recurrence.
On the basis of our series, bypass or interposition graft
procedures, ideally with cyst excision, provide good dura-
bility with freedom from reintervention. Recurrences
are common with cyst excision procedures, particularly
when a portion of the cyst is left behind.12 This is thought
to be due to persistence of the secretory components of
the adventitial cyst. Two of our patients had ultrasound-
guided cyst aspiration and one presented with recurrent
symptoms 28 days after the initial procedure. He was
treated with excision of the cyst and vein interposition
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simple cysts with no septations, the cysts in patients
with ACD have complex morphology, and the contents
of the cyst are more mucoid and gelatinous,2,12-14 so dif-
ﬁculties in draining the cyst contents with a single aspi-
ration are not unexpected. Furthermore, the contents
of the cyst also contain high concentrations of hyaluron-
ic acid and so are difﬁcult to extract through small-
gauge needles. Whereas drainage techniques have
been described in the literature,15,16 multiple reports
identify recurrence after cyst drainage alone.17-19
The primary limitation of this study is its retrospective
nature, so we could not prevent patient selection bias
regarding patient management or determine which fac-
tors contributed to the decision-making process. In addi-
tion, imaging modalities and criteria for diagnosis and
treatment were not standardized and varied by institu-
tion and surgeon. Given the rarity of ACD, treatment stra-
tegies have been guided predominantly by case reports,
which lack the power to offer convincing evidence of su-
periority. The collaboration of centers in our study allows
a more robust statistical analysis than has been previ-
ously available.
CONCLUSIONS
This multi-institutional experience in managing ACD
supports previous case reports showing that the popliteal
artery is the most common site for involvement and that
claudication is the most common presenting symptom.
Noninvasive imaging modalities are frequently used for
diagnosis. Of the currently available treatment options
for patients with ACD, cyst resection with interposition
or bypass graft is associated with the greatest likelihood
of resolution of symptoms and reduced need for reinter-
vention due to cyst recurrence. Cyst drainage alone may
result in recurrence and the need for reintervention.AUTHOR CONTRIBUTIONS
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